文献速递糖尿病肥胖与代谢综合征

人血清中三种循环T-钙黏蛋白形式的鉴定及其临床关联

Identification and Clinical Associations of 3 Forms of Circulating T-cadherin in Human Serum.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该研究开发了新型单克隆抗体和酶联免疫吸附试验,在混合人血清中鉴定出三种可溶性T-钙黏蛋白形式,并在183例日本2型糖尿病患者中横断面测量其血清浓度。

要点

  • 人血清中存在三种可溶性T-钙黏蛋白:130-kDa(含前结构域)、100-kDa(成熟型)和30-kDa(前结构域)。
  • 30-kDa前结构域与2型糖尿病患者的多个临床参数相关。

核心结论

  • 鉴定了三种新型可溶性T-钙黏蛋白形式,其作为疾病标志物或脂联素功能生物标志物的重要性及可能的生物活性需进一步研究。

研究设计与样本

  • 横断面观察性研究,使用新开发的单克隆抗体和酶联免疫吸附试验分析混合人血清,并测量183例日本2型糖尿病患者的血清T-钙黏蛋白浓度。

主要发现

  • 人血清中存在130-kDa(含前结构域)、100-kDa(成熟型)和30-kDa(前结构域)三种可溶性T-钙黏蛋白形式。
  • 30-kDa前结构域与2型糖尿病患者的多个临床参数相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: T-cadherin (T-cad) is a glycosylphosphatidylinositol (GPI)-anchored cadherin that mediates adiponectin to induce exosome biogenesis and secretion, protect cardiovascular tissues, promote muscle regeneration, and stimulate therapeutic heart protection by transplanted mesenchymal stem cells. CDH13, the gene locus of T-cad, affects plasma adiponectin levels most strongly, in addition to affecting cardiovascular disease risk and glucose homeostasis. Recently, it has been suggested that T-cad exists in human serum, although the details are still unclear. OBJECTIVE: To validate the existence of T-cad forms in human serum and investigate the association with clinical parameters of type 2 diabetes patients. METHODS: Using newly developed monoclonal antibodies against T-cad, pooled human serum was analyzed, and novel T-cad enzyme-linked immunosorbent assays (ELISAs) were developed. The serum T-cad concentrations of 183 Japanese type 2 diabetes patients were measured in a cross-sectional observational study. The main outcome measure was the existence of soluble T-cad in human serum. RESULTS: There were 3 forms of soluble T-cad: a 130-kDa form with a prodomain, a 100-kDa mature form, and a 30-kDa prodomain in human serum. Using newly developed ELISAs to measure them simultaneously, we found that the 130-kDa form of T-cad positively correlated with plasma adiponectin (r = 0.28, P < .001), although a physiological interaction with adiponectin was not observed in serum. The unique 30-kDa prodomain was associated with several clinical parameters in diabetes patients. CONCLUSION: We identified 3 novel forms of soluble T-cad. Their importance as disease markers and/or biomarkers of adiponectin function and the possible bioactivity of the respective molecules require further investigation.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Fukuda S, Kita S, Miyashita K, et al. Identification and Clinical Associations of 3 Forms of Circulating T-cadherin in Human Serum. J Clin Endocrinol Metab. 2021. PMID: 33539522. doi:10.1210/clinem/dgab066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。